- Home
- PROK vs FRGE Comparison
PROK vs FRGE Comparison
Compare PROK & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- FRGE
- Stock Information
- Founded
- PROK 2015
- FRGE 2014
- Country
- PROK United States
- FRGE United States
- Employees
- PROK 204
- FRGE N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- FRGE Computer Software: Prepackaged Software
- Sector
- PROK Health Care
- FRGE Technology
- Exchange
- PROK Nasdaq
- FRGE Nasdaq
- Market Cap
- PROK 334.8M
- FRGE 262.8M
- IPO Year
- PROK N/A
- FRGE N/A
- Fundamental
- Price
- PROK $2.47
- FRGE $16.96
- Analyst Decision
- PROK Buy
- FRGE Buy
- Analyst Count
- PROK 5
- FRGE 5
- Target Price
- PROK $6.25
- FRGE $35.50
- AVG Volume (30 Days)
- PROK 2.4M
- FRGE 86.7K
- Earning Date
- PROK 11-11-2025
- FRGE 11-05-2025
- Dividend Yield
- PROK N/A
- FRGE N/A
- EPS Growth
- PROK N/A
- FRGE N/A
- EPS
- PROK N/A
- FRGE N/A
- Revenue
- PROK $527,000.00
- FRGE $90,840,000.00
- Revenue This Year
- PROK $265.05
- FRGE $32.56
- Revenue Next Year
- PROK N/A
- FRGE $21.75
- P/E Ratio
- PROK N/A
- FRGE N/A
- Revenue Growth
- PROK N/A
- FRGE 14.78
- 52 Week Low
- PROK $0.46
- FRGE $6.60
- 52 Week High
- PROK $7.13
- FRGE $24.90
- Technical
- Relative Strength Index (RSI)
- PROK 50.86
- FRGE 39.01
- Support Level
- PROK $2.12
- FRGE $16.80
- Resistance Level
- PROK $3.05
- FRGE $18.93
- Average True Range (ATR)
- PROK 0.23
- FRGE 1.01
- MACD
- PROK 0.03
- FRGE -0.18
- Stochastic Oscillator
- PROK 38.17
- FRGE 13.50
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.